Joseph Mikhael, a hematologist at Mayo Clinic in Arizona, discusses study findings that show how CyBorD, a chemotherapy drug combination has been successful in improving the lives of patients with AL amyloidosis. This incurable disease produces abnormal proteins in the bone marrow which travel to major organs of the body, leaving deposits that damage organs like the heart and kidneys.

Read more about this discovery.